Severe Pediatric Asthma Therapy: Mepolizumab
There is a growing need for advanced treatment in children with persistent and severe asthma symptoms. As a matter of fact, between 2 and 5% of asthmatic children experience repeated hospitalizations and poor quality of life despite optimized treatment with inhaled glucocorticoid plus a second contr...
Saved in:
Main Authors: | Nicola Ullmann (Author), Francesca Peri (Author), Olivia Florio (Author), Federica Porcaro (Author), Elisa Profeti (Author), Alessandro Onofri (Author), Renato Cutrera (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficult and Severe Asthma in Children
by: Federica Porcaro, et al.
Published: (2020) -
Severe Asthma and Allergy: A Pediatric Perspective
by: Stefania Arasi, et al.
Published: (2019) -
Asthma: Differential Diagnosis and Comorbidities
by: Nicola Ullmann, et al.
Published: (2018) -
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
by: Mattia Giovannini, et al.
Published: (2019) -
Mepolizumab in Severe Pediatric Asthma: Certainties and Doubts through a Single-Center Experience and Review of the Literature
by: Marco Maglione, et al.
Published: (2024)